A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of ...

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

The Department of Health and Human Services is terminating around $500 million in BARDA contracts associated with mRNA ...

Just days after telling AstraZeneca how proud he was at its $50 billion investment strategy for the US, President Donald ...

76% of patients in the Dupixent trial reached ≥75% improvement in eczema severity at 24 weeks. Sanofi has tripled Beyfortus production and doubled manufacturing sites since its 2023 launch. PPI ...

AstraZeneca has outlined plans to invest £37billion in the US as Donald Trump’s pharmaceutical tariffs loom – fuelling fears that it will ditch its London listing. The FTSE 100 drug maker ...

The Department of Health and Human Services (HHS) has announced a plan to end mRNA vaccine work funded by the Biomedical ...